{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:24:47Z","timestamp":1762100687003},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1007\/s11916-003-0063-8","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T05:33:33Z","timestamp":1180848813000},"page":"466-474","source":"Crossref","is-referenced-by-count":27,"title":["Current and potential future drug therapies for tension-type headache"],"prefix":"10.1007","volume":"7","author":[{"given":"Sait","family":"Ashina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Messoud","family":"Ashina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"63_CR1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.279.5.381","volume":"279","author":"BS Schwartz","year":"1998","unstructured":"Schwartz BS, Stewart WF, Simon D, Lipton RB: Epidemiology of tension-type headache. JAMA 1998, 279:381\u2013383.","journal-title":"JAMA"},{"key":"63_CR2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0895-4356(91)90147-2","volume":"44","author":"BK Rasmussen","year":"1991","unstructured":"Rasmussen BK, Jensen R, Schroll M, Olesen J: Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991, 44:1147\u20131157.","journal-title":"J Clin Epidemiol"},{"key":"63_CR3","unstructured":"Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988, 8(suppl 7):1\u201396."},{"issue":"suppl 2","key":"63_CR4","doi-asserted-by":"crossref","first-page":"225S","DOI":"10.1111\/j.1365-2125.1980.tb01804.x","volume":"10","author":"B Graffenried von","year":"1980","unstructured":"von Graffenried B, Nuesch E: Non-migrainous headache for the evaluation of oral analgesics. Br J Clin Pharmacol 1980, 10(suppl 2):225S-231S.","journal-title":"Br J Clin Pharmacol"},{"key":"63_CR5","doi-asserted-by":"crossref","first-page":"206z","DOI":"10.1111\/j.1526-4610.1983.hed2305206.x","volume":"23","author":"S Diamond","year":"1983","unstructured":"Diamond S: Ibuprofen versus aspirin and placebo in the treatment of muscle contraction headache. Headache 1983, 23:206z-210z.","journal-title":"Headache"},{"key":"63_CR6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1526-4610.1987.hed2702090.x","volume":"27","author":"M Langemark","year":"1987","unstructured":"Langemark M, Olesen J: Effervescent ASA versus solid ASA in the treatment of tension headache: a double-blind, placebocontrolled study. Headache 1987, 27:90\u201395.","journal-title":"Headache"},{"key":"63_CR7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1046\/j.1468-2982.2001.00216.x","volume":"21","author":"P Martinez-Martin","year":"2001","unstructured":"Martinez-Martin P, Raffaelli E Jr, Titus F, et al.: Efficacy and safety of metamizol vs acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo- and active-controlled, multicentre study. Cephalalgia 2001, 21:604\u2013610.","journal-title":"Cephalalgia"},{"key":"63_CR8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1468-2982.1995.1506531.x","volume":"15","author":"J Nebe","year":"1995","unstructured":"Nebe J, Heier M, Diener HC: Low-dose ibuprofen in selfmedication of mild to moderate headache: a comparison with acetylsalicylic acid and placebo. Cephalalgia 1995, 15:531\u2013535.","journal-title":"Cephalalgia"},{"key":"63_CR9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0002-9343(83)90526-0","volume":"74","author":"BH Peters","year":"1983","unstructured":"Peters BH, Fraim CJ, Masel BE: Comparison of 650 mg aspirin and 1000 mg acetaminophen with each other, and with placebo in moderately severe headache. Am J Med 1983, 74:36\u201342.","journal-title":"Am J Med"},{"key":"63_CR10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1526-4610.1976.hed1606280.x","volume":"16","author":"RE Ryan","year":"1977","unstructured":"Ryan RE: Motrin: a new agent for the symptomatic treatment of muscle contraction headache. Headache 1977, 16:280\u2013283.","journal-title":"Headache"},{"key":"63_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1468-2982.2003.00470.x","volume":"23","author":"TJ Steiner","year":"2003","unstructured":"Steiner TJ, Lange R, Voelker M: Aspirin in episodic tensiontype headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia 2003, 23:59\u201366.","journal-title":"Cephalalgia"},{"key":"63_CR12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1468-2982.1996.1602117.x","volume":"16","author":"CG Dahlof","year":"1996","unstructured":"Dahlof CG, Jacobs LD: Ketoprofen, paracetamol, and placebo in the treatment of episodic tension-type headache. Cephalalgia 1996, 16:117\u2013123.","journal-title":"Cephalalgia"},{"key":"63_CR13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1526-4610.1998.3808579.x","volume":"38","author":"DR Mehlisch","year":"1998","unstructured":"Mehlisch DR, Weaver M, Fladung B: Ketoprofen, acetaminophen, and placebo in the treatment of tension headache. Headache 1998, 38:579\u2013589.","journal-title":"Headache"},{"key":"63_CR14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/clpt.1994.179","volume":"56","author":"JR Migliardi","year":"1994","unstructured":"Migliardi JR, Armellino JJ, Friedman M, et al.: Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther 1994, 56:576\u2013586.","journal-title":"Clin Pharmacol Ther"},{"key":"63_CR15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1526-4610.2000.00087.x","volume":"40","author":"B Packman","year":"2000","unstructured":"Packman B, Packman E, Doyle G, et al.: Solubilized ibuprofen: evaluation of onset, relief, and safety of a novel formulation in the treatment of episodic tension-type headache. Headache 2000, 40:561\u2013567.","journal-title":"Headache"},{"key":"63_CR16","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1468-2982.2002.00419.x","volume":"22","author":"MJ Prior","year":"2002","unstructured":"Prior MJ, Cooper KM, May LG, Bowen DL: Efficacy and safety of acetaminophen and naproxen in the treatment of tensiontype headache: a randomized, double-blind, placebocontrolled trial. Cephalalgia 2002, 22:740\u2013748.","journal-title":"Cephalalgia"},{"key":"63_CR17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/clpt.1991.143","volume":"50","author":"BP Schachtel","year":"1991","unstructured":"Schachtel BP, Thoden WR, Konerman JP, et al.: Headache pain model for assessing and comparing the efficacy of over-thecounter analgesic agents. Clin Pharmacol Ther 1991, 50:322\u2013329.","journal-title":"Clin Pharmacol Ther"},{"key":"63_CR18","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/j.1552-4604.1996.tb04165.x","volume":"36","author":"BP Schachtel","year":"1996","unstructured":"Schachtel BP, Furey SA, Thoden WR: Nonprescription ibuprofen and acetaminophen in the treatment of tensiontype headache. J Clin Pharmacol 1996, 36:1120\u20131125.","journal-title":"J Clin Pharmacol"},{"key":"63_CR19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1468-2982.1998.1801038.x","volume":"18","author":"TJ Steiner","year":"1998","unstructured":"Steiner TJ, Lange R: Ketoprofen (25 mg) in the symptomatic treatment of episodic tension-type headache: double-blind placebo-controlled comparison with acetaminophen (1000 mg). Cephalalgia 1998, 18:38\u201343.","journal-title":"Cephalalgia"},{"key":"63_CR20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1526-4610.1987.hed2707392.x","volume":"27","author":"DS Miller","year":"1987","unstructured":"Miller DS, Talbot CA, Simpson W, Korey A: A comparison of naproxen sodium, acetaminophen and placebo in the treatment of muscle contraction headache. Headache 1987, 27:392\u2013396.","journal-title":"Headache"},{"key":"63_CR21","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/j.1552-4604.1996.tb04165.x","volume":"36","author":"BP Schachtel","year":"1996","unstructured":"Schachtel BP, Furey SA, Thoden WR: Nonprescription ibuprofen and acetaminophen in the treatment of tensiontype headache. J Clin Pharmacol 1996, 36:1120\u20131125.","journal-title":"J Clin Pharmacol"},{"key":"63_CR22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1468-2982.2001.00143.x","volume":"21","author":"ME Bigal","year":"2001","unstructured":"Bigal ME, Bordini CA, Speciali JG: Intravenous metamizol (Dipyrone) in acute migraine treatment and in episodic tension-type headache: a placebo-controlled study. Cephalalgia 2001, 21:90\u201395.","journal-title":"Cephalalgia"},{"key":"63_CR23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1526-4610.1988.hed2807471.x","volume":"28","author":"BP Schachtel","year":"1988","unstructured":"Schachtel BP, Thoden WR: Onset of action of ibuprofen in the treatment of muscle-contraction headache. Headache 1988, 28:471\u2013474.","journal-title":"Headache"},{"key":"63_CR24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1067\/mcp.2000.109353","volume":"68","author":"S Diamond","year":"2000","unstructured":"Diamond S, Balm TK, Freitag FG: Ibuprofen plus caffeine in the treatment of tension-type headache. Clin Pharmacol Ther 2000, 68:312\u2013319.","journal-title":"Clin Pharmacol Ther"},{"key":"63_CR25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/WNL.50.2.507","volume":"50","author":"RN Harden","year":"1998","unstructured":"Harden RN, Rogers D, Fink K, Gracely RH: Controlled trial of ketorolac in tension-type headache. Neurology 1998, 50:507\u2013509.","journal-title":"Neurology"},{"key":"63_CR26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1090-3801(02)00094-0","volume":"7","author":"F Kubitzek","year":"2003","unstructured":"Kubitzek F, Ziegler G, Gold MS, et al.: Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur J Pain 2003, 7:155\u2013162.","journal-title":"Eur J Pain"},{"key":"63_CR27","doi-asserted-by":"crossref","unstructured":"Van GervenJMA, Schoemaker RC, Jacobs LD, et al.: Selfmedication of single headache episode with ketoprofen, ibuprofen, or placebo, home-monitored with an electronic patient diary. Br J Clin Pharmacol 1996, 475\u2013481.","DOI":"10.1046\/j.1365-2125.1996.43613.x"},{"key":"63_CR28","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2165\/00003495-199957060-00016","volume":"57","author":"W McNeely","year":"1999","unstructured":"McNeely W, Goa KL: Diclofenac-potassium in migraine: a review. Drugs 1999, 57:991\u20131003.","journal-title":"Drugs"},{"key":"63_CR29","first-page":"69","volume":"10","author":"AP Friedman","year":"1987","unstructured":"Friedman AP, DiSerio FJ: Symptomatic treatment of chronically recurring tension headache: a placebocontrolled, multicenter investigation of Fioricet and acetaminophen with codeine. Clin Ther 1987, 10:69\u201381.","journal-title":"Clin Ther"},{"key":"63_CR30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11940-001-0052-3","volume":"3","author":"R Jensen","year":"2001","unstructured":"Jensen R: Tension-type headache. Curr Treat Options Neurol 2001, 3:169\u2013180.","journal-title":"Curr Treat Options Neurol"},{"key":"63_CR31","first-page":"661","volume-title":"The Headaches","author":"NT Mathew","year":"2000","unstructured":"Mathew NT, Schoenen J: Acute pharmacotherapy of tensiontype headache. In The Headaches. Edited by Olesen J, Tfelt-Hansen P, Welch KM. Philadelphia: Lippincott-Raven; 2000:661\u2013666. A review of numerous studies on the acute pharmacologic treatment of tension-type headache."},{"key":"63_CR32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1468-2982.1992.00375.x","volume":"12","author":"J Brennum","year":"1992","unstructured":"Brennum J, Kjeldsen M, Olesen J: The 5-HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache. Cephalalgia 1992, 12:375\u2013379.","journal-title":"Cephalalgia"},{"key":"63_CR33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1468-2982.1997.1705588.x","volume":"17","author":"RK Cady","year":"1997","unstructured":"Cady RK, Gutterman D, Saiers JA, Beach ME: Responsiveness of non-IHS migraine and tension-type headache to sumatriptan. Cephalalgia 1997, 17:588\u2013590.","journal-title":"Cephalalgia"},{"key":"63_CR34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1468-1331.1996.tb00184.x","volume":"3","author":"J Brennum","year":"1996","unstructured":"Brennum J, Brinck T, Schriver L, et al.: Sumatriptan has no clinically relevant effect in the treatment of episodic tensiontype headache. Eur J Neurol 1996, 3:23\u201328.","journal-title":"Eur J Neurol"},{"key":"63_CR35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJMra010917","volume":"346","author":"PJ Goadsby","year":"2002","unstructured":"Goadsby PJ, Lipton RB, Ferrari MD: Migraine: current understanding and treatment. N Engl J Med 2002, 346:257\u2013270.","journal-title":"N Engl J Med"},{"key":"63_CR36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1468-2982.2000.00070.x","volume":"20","author":"L Bendtsen","year":"2000","unstructured":"Bendtsen L: Central sensitization in tension-type headache: possible pathophysiological mechanisms. Cephalalgia 2000, 20:486\u2013508.","journal-title":"Cephalalgia"},{"key":"63_CR37","first-page":"667","volume-title":"The Headaches","author":"NT Mathew","year":"2000","unstructured":"Mathew NT, Bendtsen L: Prophylactic pharmacotherapy of tension-type headache. In The Headaches. Edited by Olesen J, Tfelt-Hansen P, Welch KM. Philadelphia: Lippincott-Raven; 2000:667\u2013673. A comprehensive and interesting review of the pharmacologic prophylactic therapy of chronic tension-type headache."},{"key":"63_CR38","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(64)91866-5","volume":"1","author":"JW Lance","year":"1964","unstructured":"Lance JW, Curran DA: Treatment of chronic tension headache. Lancet 1964, 1:1236\u20131239.","journal-title":"Lancet"},{"key":"63_CR39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1526-4610.1971.hed1103110.x","volume":"11","author":"S Diamond","year":"1971","unstructured":"Diamond S, Baltes BJ: Chronic tension headache treated with amitriptyline: a double-blind study. Headache 1971, 11:110\u2013116.","journal-title":"Headache"},{"key":"63_CR40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-3959(94)90077-9","volume":"59","author":"H Gobel","year":"1994","unstructured":"Gobel H, Hamouz V, Hansen C, et al.: Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity, but does not alter pericranial muscle activity readings. Pain 1994, 59:241\u2013249.","journal-title":"Pain"},{"key":"63_CR41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1468-2982.1994.1402149.x","volume":"14","author":"V Pfaffenrath","year":"1994","unstructured":"Pfaffenrath V, Diener HC, Isler H, et al.: Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multicentre controlled study. Cephalalgia 1994, 14:149\u2013155.","journal-title":"Cephalalgia"},{"key":"63_CR42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jnnp.61.3.285","volume":"61","author":"L Bendtsen","year":"1996","unstructured":"Bendtsen L, Jensen R, Olesen J: A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996, 61:285\u2013290.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"63_CR43","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1468-2982.2000.00087.x","volume":"20","author":"L Bendtsen","year":"2000","unstructured":"Bendtsen L, Jensen R: Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia 2000, 20:603\u2013610.","journal-title":"Cephalalgia"},{"key":"63_CR44","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1001\/jama.285.17.2208","volume":"285","author":"KA Holroyd","year":"2001","unstructured":"Holroyd KA, O\u2019Donnell FJ, Stensland M, et al.: Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 2001, 285:2208\u20132215. A well-conducted 6-month trial of amitriptyline and stress management therapy in chronic tension-type headache.","journal-title":"JAMA"},{"key":"63_CR45","first-page":"21","volume":"26","author":"J Sawynok","year":"2001","unstructured":"Sawynok J, Esser MJ, Reid AR: Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001, 26:21\u201329.","journal-title":"J Psychiatry Neurosci"},{"key":"63_CR46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0028-3908(93)90173-Z","volume":"32","author":"Y Watanabe","year":"1993","unstructured":"Watanabe Y, Saito H, Abe K: Tricyclic antidepressants block NMDA receptor-mediated synaptic responses and induction of long-term potentiation in rat hippocampal slices. Neuropharmacology 1993, 32:479\u2013486.","journal-title":"Neuropharmacology"},{"key":"63_CR47","first-page":"301","volume-title":"Novel Aspects of Pain Management Opioids and Beyond","author":"A Eschalier","year":"1997","unstructured":"Eschalier A, Ardid D, Dubray C: Tricyclic and other antidepressants as analgesics. In Novel Aspects of Pain Management Opioids and Beyond. Edited by Sawynok JC, Cowan A. Hoboken, NJ: Wiley; 1997:301\u2013319."},{"key":"63_CR48","first-page":"873","volume":"50","author":"NN Singh","year":"2002","unstructured":"Singh NN, Misra S: Sertraline in chronic tension-type headache. J Assoc Physicians India 2002, 50:873\u2013878.","journal-title":"J Assoc Physicians India"},{"key":"63_CR49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1526-4610.1994.hed3401044.x","volume":"34","author":"V Manna","year":"1994","unstructured":"Manna V, Bolino F, Di Cicco L: Chronic tension-type headache, mood depression, and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache 1994, 34:44\u201349.","journal-title":"Headache"},{"key":"63_CR50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1526-4610.1994.hed3401020.x","volume":"34","author":"M Langemark","year":"1994","unstructured":"Langemark M, Olesen J: Sulpiride and paroxetine in the treatment of chronic tension-type headache: an explanatory double-blind trial. Headache 1994, 34:20\u201324.","journal-title":"Headache"},{"key":"63_CR51","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1526-4610.1992.hed3210509.x","volume":"32","author":"R Fogelholm","year":"1992","unstructured":"Fogelholm R, Murros K: Tizanidine in chronic tension-type headache: a placebo-controlled, double-blind, cross-over study. Headache 1992, 32:509\u2013513.","journal-title":"Headache"},{"key":"63_CR52","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1526-4610.2000.040008633.x","volume":"40","author":"K Murros","year":"2000","unstructured":"Murros K, Kataja M, Hedman C, et al.: Modified-release formulation of tizanidine in chronic tension-type headache. Headache 2000, 40:633\u2013637.","journal-title":"Headache"},{"key":"63_CR53","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11916-999-0069-y","volume":"3","author":"BM Guyer","year":"1999","unstructured":"Guyer BM: Mechanism of botulinum toxin in the relief of chronic pain. Curr Rev Pain 1999, 3:427\u2013431.","journal-title":"Curr Rev Pain"},{"issue":"suppl 4","key":"63_CR54","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1111\/j.1468-1331.1999.tb00044.x","volume":"6","author":"J Smuts","year":"1999","unstructured":"Smuts J, Baker MK, Smuts HM: Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol 1999, 6(suppl 4):S99-S102.","journal-title":"Eur J Neurol"},{"key":"63_CR55","first-page":"455","volume":"19","author":"H G\u00f6bel","year":"1999","unstructured":"G\u00f6bel H, Lindner V, Krack PK, et al.: Treatment of chronic tension-type headache with botulinum toxin [Abstract]. Cephalalgia 1999, 19:455.","journal-title":"Cephalalgia"},{"key":"63_CR56","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1526-4610.2000.00044.x","volume":"40","author":"JD Rollnik","year":"2000","unstructured":"Rollnik JD, Tanneberger O, Schubert M, et al.: Treatment of tension-type headache with botulinum toxin type A: a doubleblind, placebo-controlled study. Headache 2000, 40:300\u2013305.","journal-title":"Headache"},{"key":"63_CR57","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1526-4610.2001.041007658.x","volume":"41","author":"WJ Schmitt","year":"2001","unstructured":"Schmitt WJ, Slowey E, Fravi N, et al.: Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001, 41:658\u2013664.","journal-title":"Headache"},{"key":"63_CR58","doi-asserted-by":"crossref","first-page":"3D","DOI":"10.1016\/S0002-9149(02)02231-2","volume":"89","author":"C Bombardier","year":"2002","unstructured":"Bombardier C: An evidence-based evaluation of the gastrointestinal safety of coxibs. Am J Cardiol 2002, 89:3D-9D.","journal-title":"Am J Cardiol"},{"key":"63_CR59","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1213\/01.ANE.0000061461.55712.C5","volume":"96","author":"NM Gajraj","year":"2003","unstructured":"Gajraj NM: Cyclooxygenase-2 inhibitors. Anesth Analg 2003, 96:1720\u20131738.","journal-title":"Anesth Analg"},{"key":"63_CR60","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1523\/JNEUROSCI.21-16-05847.2001","volume":"21","author":"TL Yaksh","year":"2001","unstructured":"Yaksh TL, Dirig DM, Conway CM, et al.: The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci 2001, 21:5847\u20135853.","journal-title":"J Neurosci"},{"key":"63_CR61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1526-4610.1985.hed2505273.x","volume":"25","author":"R Fogelholm","year":"1985","unstructured":"Fogelholm R, Murros K: Maprotiline in chronic tension headache: a double-blind cross-over study. Headache 1985, 25:273\u2013275.","journal-title":"Headache"},{"key":"63_CR62","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1526-4610.1990.hed3003118.x","volume":"30","author":"M Langemark","year":"1990","unstructured":"Langemark M, Loldrup D, Bech P, Olesen J: Clomipramine and mianserin in the treatment of chronic tension headache: a double-blind, controlled study. Headache 1990, 30:118\u2013121.","journal-title":"Headache"},{"key":"63_CR63","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0165-0327(98)00222-5","volume":"51","author":"WD Horst","year":"1998","unstructured":"Horst WD, Preskorn SH: Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. J Affect Disord 1998, 51:237\u2013254.","journal-title":"J Affect Disord"},{"key":"63_CR64","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/106002809502900410","volume":"29","author":"WA Morton","year":"1995","unstructured":"Morton WA, Sonne SC, Verga MA: Venlafaxine: a structurally unique and novel antidepressant. Ann Pharmacother 1995, 29:387\u2013395.","journal-title":"Ann Pharmacother"},{"key":"63_CR65","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1526-4610.2000.00089.x","volume":"40","author":"LC Adelman","year":"2000","unstructured":"Adelman LC, Adelman JU, Von SeggernR, Mannix LK: Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 2000, 40:572\u2013580.","journal-title":"Headache"},{"key":"63_CR66","unstructured":"Kulaksizoglu IB, Cakir S, Ertas M: Treatment of tension-type headache with mirtazapine [Abstract]. Proceedings of the 12th International Headache Research Seminar. Copenhagen: March 7\u20139, 2003."},{"key":"63_CR67","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0404.1997.tb00277.x","volume":"96","author":"DD Mitsikostas","year":"1997","unstructured":"Mitsikostas DD, Gatzonis S, Thomas A, Ilias A: Buspirone vs amitriptyline in the treatment of chronic tension-type headache. Acta Neurol Scand 1997, 96:247\u2013251.","journal-title":"Acta Neurol Scand"},{"key":"63_CR68","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2165\/00003495-200060050-00005","volume":"60","author":"IW Tremont-Lukats","year":"2000","unstructured":"Tremont-Lukats IW, Megeff C, Backonja MM: Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs 2000, 60:1029\u20131052.","journal-title":"Drugs"},{"key":"63_CR69","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00023210-200115050-00001","volume":"15","author":"SJ Czuczwar","year":"2001","unstructured":"Czuczwar SJ, Patsalos PN: The new generation of GABA enhancers: potential in the treatment of epilepsy. CNS Drugs 2001, 15:339\u2013350.","journal-title":"CNS Drugs"},{"key":"63_CR70","first-page":"145","volume":"151","author":"G Trapani Di","year":"2000","unstructured":"Di Trapani G, Mei D, Marra C, et al.: Gabapentin in the prophylaxis of migraine: a double-blind, randomized, placebo-controlled study. Clin Ther 2000, 151:145\u2013148.","journal-title":"Clin Ther"},{"key":"63_CR71","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1046\/j.1526-4610.2001.01190.x","volume":"41","author":"JR Storey","year":"2001","unstructured":"Storey JR, Calder CS, Hart DE, Potter DL: Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache 2001, 41:968\u2013975.","journal-title":"Headache"},{"key":"63_CR72","first-page":"126","volume":"96","author":"M Lenaerts","year":"1996","unstructured":"Lenaerts M, Bastings E, Sianard J, Schoenen J: Sodium valproate in severe migraine and tension-type headache: an open study of long-term efficacy and correlation with blood levels. Acta Neurol Belg 1996, 96:126\u2013129.","journal-title":"Acta Neurol Belg"},{"key":"63_CR73","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1126\/science.288.5472.1765","volume":"288","author":"CJ Woolf","year":"2000","unstructured":"Woolf CJ, Salter MW: Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765\u20131769.","journal-title":"Science"},{"key":"63_CR74","doi-asserted-by":"crossref","unstructured":"Ashina M: Neurobiology of chronic tension-type headache. Cephalalgia, in press. A thorough review on the role of nitric oxide in chronic tension-type headache.","DOI":"10.1111\/j.1468-2982.2003.00644.x"},{"key":"63_CR75","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1749-6632.2001.tb05821.x","volume":"933","author":"WD Willis","year":"2001","unstructured":"Willis WD: Role of neurotransmitters in sensitization of pain responses. Ann N Y Acad Sci 2001, 933:142\u2013156.","journal-title":"Ann N Y Acad Sci"},{"key":"63_CR76","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0304-3959(91)90100-C","volume":"44","author":"CJ Woolf","year":"1991","unstructured":"Woolf CJ, Thompson SW: The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of postinjury pain hypersensitivity states. Pain 1991, 44:293\u2013299.","journal-title":"Pain"},{"key":"63_CR77","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/381793a0","volume":"381","author":"JG Gu","year":"1996","unstructured":"Gu JG, Albuquerque C, Lee CJ, MacDermott AB: Synaptic strengthening through activation of Ca2+-permeable AMPA receptors. Nature 1996, 381:793\u2013796.","journal-title":"Nature"},{"key":"63_CR78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.neuro.25.112701.142758","volume":"25","author":"R Malinow","year":"2002","unstructured":"Malinow R, Malenka RC: AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 2002, 25:103\u2013126.","journal-title":"Annu Rev Neurosci"},{"key":"63_CR79","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00001756-199803090-00005","volume":"9","author":"J Wu","year":"1998","unstructured":"Wu J, Lin Q, McAdoo DJ, Willis WD: Nitric oxide contributes to central sensitization following intradermal injection of capsaicin. Neuroreport 1998, 9:589\u2013592.","journal-title":"Neuroreport"},{"key":"63_CR80","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0304-3959(97)00063-8","volume":"72","author":"J Mao","year":"1997","unstructured":"Mao J, Price DD, Zhu J, et al.: The inhibition of nitric oxideactivated poly (ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat. Pain 1997, 72:355\u2013366.","journal-title":"Pain"},{"key":"63_CR81","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0304-3959(96)03039-4","volume":"66","author":"JX Hao","year":"1996","unstructured":"Hao JX, Xu XJ: Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered nitric oxide synthase inhibitors. Pain 1996, 66:313\u2013319.","journal-title":"Pain"},{"key":"63_CR82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0028-3908(92)90175-O","volume":"31","author":"JE Haley","year":"1992","unstructured":"Haley JE, Dickenson AH, Schachter M: Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology 1992, 31:251\u2013258.","journal-title":"Neuropharmacology"},{"key":"63_CR83","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1468-2982.2001.00007.x","volume":"21","author":"NM Ramadan","year":"2001","unstructured":"Ramadan NM, Sang C, Chappell A, et al.: IV LY293558, an AMPA\/KA receptor antagonist, is effective in migraine [Abstract]. Cephalalgia 2001, 21:267\u2013268.","journal-title":"Cephalalgia"},{"key":"63_CR84","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0140-6736(98)01079-4","volume":"353","author":"M Ashina","year":"1999","unstructured":"Ashina M, Lassen LH, Bendtsen L, et al.: Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet 1999, 353:287\u2013289. An important study suggesting that inhibition of nitric oxide synthase may become a novel principle in the treatment of chronic tensiontype headache and other pain conditions.","journal-title":"Lancet"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-003-0063-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-003-0063-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-003-0063-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:34:10Z","timestamp":1559435650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-003-0063-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s11916-003-0063-8","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}